Nivolumab as a safe and effective treatment in an HIV patient with refractory Hodgkin lymphoma

被引：7
|
作者：
Serrao, Alessandra [1 ]
Canichella, Martina [1 ]
De Luca, Maria Lucia [1 ]
Tartaglia, Germana [1 ]
Annechini, Giorgia [1 ]
D'Elia, Gianna Maria [1 ]
Pulsoni, Alessandro [1 ]
机构：
[1] Sapienza Univ Rome, Dept Cellular Biotecnol & Hemathol, Via Benevento 6, I-00161 Rome, Italy
来源：
ANNALS OF HEMATOLOGY | 2019年 / 98卷 / 06期
关键词：
STEM-CELL TRANSPLANTATION; BRENTUXIMAB VEDOTIN; MULTICENTER;
D O I：
10.1007/s00277-018-3541-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1505 / 1506
页数：2
相关论文
共 50 条
  • [41] High dose sequential chemotherapy: An effective treatment in relapsed and refractory Hodgkin's lymphoma
    Nassi, L.
    Rigacci, R.
    Guidi, S.
    Lombardini, L.
    Nozzoli, C.
    Gozzini, A.
    Mappa, S.
    Puccini, B.
    Carrai, V
    Alterini, R.
    Bernardi, F.
    Saccardi, R.
    Bosi, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 187 - 187
  • [42] Combination radiotherapy with Nivolumab for refractory classic Hodgkin lymphoma : about two cases
    De Forceville, L.
    Deau-Fischer, B.
    Franchi, P.
    Arsene-Henry, A.
    Mounat, T. Cassou
    Bouscary, D.
    Kirova, Y.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S695 - S696
  • [43] Low-dose nivolumab induced remission in refractory classical Hodgkin lymphoma
    Yu-Yan Hwang
    Pek-Lan Khong
    Yok-Lam Kwong
    Annals of Hematology, 2017, 96 : 1219 - 1220
  • [44] PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
    Ansell, Stephen M.
    Lesokhin, Alexander M.
    Borrello, Ivan
    Halwani, Ahmad
    Scott, Emma C.
    Gutierrez, Martin
    Schuster, Stephen J.
    Millenson, Michael M.
    Cattry, Deepika
    Freeman, Gordon J.
    Rodig, Scott J.
    Chapuy, Bjoern
    Ligon, Azra H.
    Zhu, Lili
    Grosso, Joseph F.
    Kim, Su Young
    Timmerman, John M.
    Shipp, Margaret A.
    Armand, Philippe
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04): : 311 - 319
  • [45] Low-dose nivolumab induced remission in refractory classical Hodgkin lymphoma
    Hwang, Yu-Yan
    Khong, Pek-Lan
    Kwong, Yok-Lam
    ANNALS OF HEMATOLOGY, 2017, 96 (07) : 1219 - 1220
  • [46] NIVOLUMAB FOR RELAPSED/REFRACTORY HODGKIN LYMPHOMA: A REAL-LIFE EXPERIENCE IN CAMPANIA
    Trastulli, F.
    Vitagliano, O.
    Della Pepa, R.
    Giordano, C.
    Rosamilio, R.
    Pezzullo, L.
    Ronconi, F.
    Ferrara, F.
    Pane, F.
    Picardi, M.
    HAEMATOLOGICA, 2019, 104 : 129 - 129
  • [47] REFRACTORY HODGKIN LYMPHOMA WITH BONE AND SPLEENIC INVOLVEMENT WITH RAPID AND COMPLETE RESPONSE TO NIVOLUMAB
    Martinez Fernandez, R.
    Sanchez Quinones, B.
    Auria Caballero, C.
    De Poo Rodriguez, M., V
    Dourdil Sahun, M., V
    Mayor Perez, L.
    Palomera Bernal, L.
    HAEMATOLOGICA, 2018, 103 : 338 - 338
  • [48] Nivolumab is Effective in Relapsed Refractory Hodgkins Lymphoma Patient Following Mismatched Allogeneic Stem Cell Transplantation
    Browning, Amy Lynn
    Patel, Rushang D.
    Ahmed, Wesam
    Mori, Shahram
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S263 - S264
  • [49] Treatment of Patients WiT Refractory Hodgkin Lymphoma
    Basara, Nadezda
    Faber, Nikolai
    Menzel, Helge
    Drewniock, Petra
    Sitskaia, Xenia
    Lukic, Stefan
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 132 - 132
  • [50] Sintilimab as salvage treatment in an HIV patient with relapsed/refractory Hodgkin: a case report
    Shi, Yang
    Li, Qiying
    Zhang, Wenjun
    Nan, Yingyu
    Yang, Tao
    Liang, Xiping
    Xiao, Chunyan
    Guo, Bingling
    Xiang, Ying
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (04) : 2414 - 2419
12345